Douglas W. Losordo - 19 Jan 2023 Form 3/A - Amendment Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Medical Officer
Signature
/s/ Douglas Losordo
Issuer symbol
CVKD
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
3/A - Amendment
Filing time
31 Mar 2023, 06:16:52 UTC
Date Of Original Report
19 Jan 2023
Previous filing
22 Dec 2022
Next filing
26 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVKD Stock Options 19 Jan 2023 Common Stock 300,000 $0.6400 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Amendment is being filed to correct the vesting commencement date and provide the vesting schedule for the stock option grant.
F2 The options to purchase shares of common stock, par value $0.001 per share, of Cadrenal Therapeutics, Inc., which options vest and become exercisable 1/12th on October 1, 2022 and the balance vests 1/12th every three (3) months thereafter, subject to the reporting person's continued service to the Company.

Remarks:

This Amendment is being filed to correct the vesting commencement date and provide the vesting schedule for the stock option grant.